Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population

Infection Control and Hospital Epidemiology

Volumn 29, Issue 9, 2008, Pages 823-828

  Song, Xiaoyan ^a,c   Bartlett, John G ^a   Speck, Kathleen ^a   Naegeli, April ^b   Carroll, Karen ^a   Perl, Trish M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; ASSAY; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; COST OF ILLNESS; DISEASE SEVERITY; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; INCIDENCE; LABORATORY TEST; LENGTH OF STAY; MORTALITY; NONHUMAN; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; WARD;

CLOSTRIDIUM DIFFICILE; COHORT STUDIES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITAL COSTS; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED;

EID: 51849124742     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/588756     Document Type: Article

References (19)

1. Kenneally C, Rosini JM, Skrupky LP, et al. Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest 2007;132:418-424.
2. MacGowan AP, Feeney R, Brown I, McCulloch SY, Reeves DS, Lovering AM. Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea. J Antimicrob Chemother 1997;39:537-541.
3. Riley TV. Antibiotic-associated diarrhoea. A costly problem. Pharmacoeconomics 1996;10:1-3.
4. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996;34:23-30.
5. Spencer RC. Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother 1998;41 Suppl C:5-12.
6. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346-353.
7. Kuijper EJ, Coignard B, Tüll P, et al. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006;12 Suppl 6:2-18.
8. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-1084.
9. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-2441.
10. Zafar AB, Gaydos LA, Furlong WB, Nguyen MH, Mennonne PA. Effectiveness of infection control program in controlling nosocomial Clostridium difficile. Am J Infect Control 1998;26:588-593.
11. Oldfield EC 3rd. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment. Rev Gastroenterol Disord 2004;4:186-195.
12. Eckstein BC, Adams DA, Eckstein EC, et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007;7:61.
13. Perencevich EN, Stone PW, Wright SB, Carmeli Y, Fisman DN, Cosgrove SE; Society for Healthcare Epidemiology of America. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007;28:1121-1133.
14. Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006;44: 1145-1149.
15. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140-145.
16. Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr. Resuscitation: how do we decide? A prospective study of physicians' preferences and the clinical course of hospitalized patients. JAMA 1986; 255:1316-1322.
17. Riley TV, Codde JP, Rouse IL. Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet 1995;345:455-456.
18. Ramaswamy R, Grover H, Corpuz M, Daniels P, Pitchumoni CS. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol 1996;91: 460-464.
19. Sunenshine RH, McDonald LC. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 2006;73: